Among patients who switched from AOM tirzepatide to a new therapy, the majority transitioned to AOM semaglutide, aligning with its status as the CVS Caremark preferred therapy
Talk to your healthcare provider to find out if tirzepatide is still in shortage and if a compounded version may be right for you
For eligible patients, Semaglutide GLP-1 injections offer a path toward better overall health, reduced weight, and a decreased risk of associated diseases, all while providing a well-tolerated and clinically proven treatment option
[4] [5] However, availability may be affected by supply constraints
Study Used AI to Analyze Real-World Patient Reports To better understand how people experience GLP-1 drugs outside of clinical trials, researchers used AI to analyze Reddit posts from 2019 to 2025
Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on October 29th, 2025